An announcement from Akeso, Inc. ( (HK:9926) ) is now available.
Akeso, Inc. has announced that its board of directors will meet on March 30, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. This meeting is crucial for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the upcoming year.
More about Akeso, Inc.
Akeso, Inc. is a company incorporated in the Cayman Islands, operating within the healthcare industry. The company is involved in the development and commercialization of pharmaceutical products, focusing on innovative therapies.
YTD Price Performance: 15.16%
Average Trading Volume: 8,229,497
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$62.74B
See more data about 9926 stock on TipRanks’ Stock Analysis page.